For early-stage breast cancer patients, genetic markers show whether chemotherapy is likely to have an impact, or if hormone therapy alone is the better option. A new lung cancer drug developed by my company, Novartis, is effective only in patients with non-small-cell lung cancer who have a particular genetic mutation.
对早期乳腺癌患者而言，基因标记物能说明化疗是否能够取得效果，还是只靠激素疗法才是更好的选择。我的公司诺华所研发的一种新肺癌药物只对发生了一种特殊基因突变的非小细胞（non-small-cell）肺癌患者有效。